Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06711965 · ClinicalTrials.gov registry record · NA
Interactive Design of Patient-Specific Molds for Tissue Shaping
A NA study of Mastectomy, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT06711965: Recruiting NA study of Mastectomy, sponsored by M.D. Anderson Cancer Center.
NCT06711965 is a NA study of Mastectomy that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 160 participants, above the 113-participant average among 8 other Mastectomy trials with a reported enrollment target (42% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06711965, a NA study of Mastectomy, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to develop clinical decision-support algorithms for designing participants-specific breast molds for tissue shaping. Autologous breast reconstruction is an important part of breast cancer rehabilitation for many participants. Our goal is to increase the efficiency of autologous breast reconstruction by helping the surgeon design participants-specific molds for shaping tissue into an acceptable breast form.
Primary Outcome
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Conditions Studied
Interventions
- PROCEDURE Standard of care reconstruction
- PROCEDURE Surgery, Breast Mold
Study Locations (1)
Texas
- The University of Texas M. D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-07-17 |
| Est. Completion | 2030-08-01 |
| Phase | NA |
What NCT06711965 shows while recruiting
NCT06711965 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 113-participant average among 8 other Mastectomy trials with a reported enrollment target (42% higher).
The record links to 1 condition, with Mastectomy appearing as the primary indexed condition, and to 2 interventions - of which Standard of care reconstruction is the first listed.
NCT06711965 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06711965 about?
NCT06711965 is a clinical study titled "Interactive Design of Patient-Specific Molds for Tissue Shaping". The goal of this study is to develop clinical decision-support algorithms for designing participants-specific breast molds for tissue shaping. Autologous breast reconstruction is an important part of breast cancer rehabilitation for many participants. Our goal is to increase the efficiency of autolo...
What is the current status of trial NCT06711965?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-07-17. Estimated completion is 2030-08-01.
What conditions does trial NCT06711965 study?
This clinical trial studies the following conditions: Mastectomy.
What interventions are being tested in trial NCT06711965?
The interventions under investigation include: Standard of care reconstruction (PROCEDURE), Surgery, Breast Mold (PROCEDURE).
Who is sponsoring clinical trial NCT06711965?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06711965 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mastectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06711965's enrollment target sits among peer trials
160 2nd of 8 the highest of 8 other Mastectomy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mastectomy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study on Pain After Breast Reconstruction
RECRUITING · NA
-
A Prospective Study of Video-assisted Exercise Program for the Breast Cancer Survivors
RECRUITING · NA
-
A Bionic Breast Project Using Neuroprosthesis to Reduce Chronic Pain After Mastectomy
RECRUITING · NA
-
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
RECRUITING · NA
-
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy
RECRUITING · NA
-
Assessment of the Interi Manifold in Implant-Based Breast Reconstruction
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI